More freedom when eating
Dr. Marc Schneider holds a Ph.D. in food chemistry and is the CEO of ineo Pharma GmbH. His mission is to communicate scientific findings in an accessible way and to help people with food intolerances lead safer, more carefree lives with a higher quality of life. He aims to use his expertise to help those affected make informed decisions about their health.
GluteoStop® was developed by Ineo Pharma GmbH for anyone who follows a gluten-free diet but doesn’t want to constantly have to go without or worry. Driven by the desire to make a low-gluten lifestyle less complicated, a handy companion for everyday life has been created—for use at home, in restaurants, while traveling, and anywhere else where hidden gluten might lurk.
Our History
Raising awareness is important to us—partly because we have family members on our team who have celiac disease and gluten sensitivity. The idea came about in 2015 during a trade show visit in the U.S. Since the raw material wasn’t yet approved in Germany, we saw an opportunity to improve the quality of life for people with gluten intolerance.
This was followed by an in-depth exploration of the topic and initial trials—product development took time. By mid-2017, the regulatory requirements in the EU were in place, and in mid-2018, GluteoStop® went on sale for the first time in Switzerland and Germany. Since then, many EU and non-EU countries have been added—and we remain committed to ensuring that our product supports gluten-free diets worldwide for the long term.
Our Journey
2015
The idea takes shape
We first came across this ingredient while visiting a trade show in the U.S. Since we have team members who are personally affected by this condition, it was clear to us: This is an opportunity to improve the quality of life for people with gluten intolerance.
2017
Legal Basis in the EU
Initially, the raw material was not approved in Germany. By mid-2017, the first regulatory requirements had been established in the EU—laying the groundwork for its market launch.
2018
Market Launch
In mid-2018, GluteoStop® went on sale for the first time in Switzerland and Germany—followed shortly thereafter by Denmark, Norway, and Sweden.
2019
Onward Through Europe
Lithuania, Romania, and Slovenia were added as additional European markets.
2020
New Markets
Italy, Belgium, and Luxembourg expanded availability.
2024
Beyond Europe
GluteoStop® expanded into new regions, including Spain and Lebanon.
2025
International
Turkey, Northern Cyprus, Azerbaijan, and the Netherlands were added. We’ll keep working to ensure that our product is supported worldwide in the long term.
Mission & Vision
Mission: GluteoStop® helps people following a gluten-free diet make their daily lives safer, more flexible, and more relaxed through a scientifically developed enzyme product.
Vision: A world where people following a gluten-free diet can live spontaneously—with confidence, freedom, and a better quality of life. Our goal is to support people worldwide in their gluten-free diets.
What Makes GluteoStop® Special
Scientific Rigor
Clinical studies confirm the effectiveness—we rely on proven evidence rather than promises.
Special Enzyme
With prolyloligopeptidase (AN-PEP), the focus is specifically on gluten—not on digestion in general.
Made in Germany
The tablets are manufactured in Germany, while the special enzyme is produced in France—where many other companies rely on Asia.
Certified Quality
Each batch is also tested by an external laboratory.
Suitable for everyday use
Mini tablets in a handy click dispenser—discreet for use on the go, at a restaurant, or while traveling.
Scientific Expert Team
Our team is also available to answer any technical questions in person.
